Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

• Autores principales: Danyu Du (Autor), Chan Liu (Autor), Mengyao Qin (Autor), Xiao Zhang (Autor), Tao Xi (Autor), Shengtao Yuan (Autor), Haiping Hao (Autor), Jing Xiong (Autor)
• Formato: Libro
• Publicado: Elsevier, 2022-02-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Hepatocellular carcinoma (HCC) is an aggressive human cancer with increasing incidence worldwide. Multiple efforts have been made to explore pharmaceutical therapies to treat HCC, such as targeted tyrosine kinase inhibitors, immune based therapies and combination of chemotherapy. However, limitation...